SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-026509
Filing Date
2021-02-03
Accepted
2021-02-03 08:21:30
Documents
15
Period of Report
2021-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d110946d8k.htm   iXBRL 8-K 45280
2 EX-99.1 d110946dex991.htm EX-99.1 25406
3 EX-99.2 d110946dex992.htm EX-99.2 8399
7 GRAPHIC g110946dsp8.jpg GRAPHIC 4220
  Complete submission text file 0001193125-21-026509.txt   227816

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20210202.xsd EX-101.SCH 3056
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20210202_lab.xml EX-101.LAB 18137
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20210202_pre.xml EX-101.PRE 11398
8 EXTRACTED XBRL INSTANCE DOCUMENT d110946d8k_htm.xml XML 3366
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 21584418
SIC: 8071 Services-Medical Laboratories